Aya Jakobovits - 31 Dec 2021 Form 5 Insider Report for Adicet Bio, Inc. (ACET)

Role
Director
Signature
/s/ Nick Harvey, Attorney-in-Fact for Aya Jakobovits
Issuer symbol
ACET
Transactions as of
31 Dec 2021
Net transactions value
-$224,314
Form type
5
Filing time
14 Feb 2022, 15:56:21 UTC
Previous filing
17 Jun 2021
Next filing
14 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACET Common Stock Sale $112,113 -7,000 -2.1% $16.02* 332,552 22 Dec 2021 See Footnote F1, F2, F3
transaction ACET Common Stock Sale $112,200 -7,000 -2.1% $16.03* 332,553 22 Dec 2021 See Footnote F1, F4, F5
transaction ACET Common Stock Gift $0 -109,488 -100% $0.000000* 0 23 Dec 2021 See Footnote F6, F7
transaction ACET Common Stock Gift $0 +29,905 +28% $0.000000 138,076 23 Dec 2021 See Footnote F6, F8
transaction ACET Common Stock Gift $0 +39,791 +12% $0.000000 372,343 23 Dec 2021 See Footnote F3, F6
transaction ACET Common Stock Gift $0 +39,792 +12% $0.000000 372,345 23 Dec 2021 See Footnote F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These sales were effected pursuant to Rule 10b5-1 trading plans previously adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.46 to $16.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' daughter is the beneficiary.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.47 to $16.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5 Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' son is the beneficiary.
F6 Represents a gift of Common Stock made on December 23, 2021.
F7 Shares transferred from a grantor retained annuity trust ("GRAT") of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits the sole annuitant and current beneficiary. Following this transaction, this GRAT was terminated.
F8 Shares held in a revocable trust of which Dr. Jakobovits and her spouse are co-trustees.

Remarks:

The Form 4s filed by Dr. Jakobovits on May 14, 2021, May 20, 2021 and June 17, 2021 (the "Prior Filings") incorrectly allocated the shares between trusts over which Dr. Jakobovits has beneficial ownership. The aggregate number of shares beneficially owned as reported in Column 5 of Table I on each of the Prior Filings was correct. Following the transactions reported on this Form 5, the shares over which Dr. Jakobovits has beneficial ownership are held in three trusts: (i) a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' daughter is the beneficiary, (ii) a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' son is the beneficiary, and (ii) a revocable trust of which Dr. Jakobovits and her spouse are co-trustees.